Ligand profile
2UL
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_32248 — Beta-lactamase SHV-12
Identifiers
Database identifiers and provenance.
- Ligand ID
2UL- PDB
4oqg- UniProt (similar protein)
Q79DR3- Target protein
- KP13_32248
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 132.9
- −1 ≤ LogP ≤ 5 0.12
- MW ≤ 500 Da 342.2
- LogP ≤ 5 0.12
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 7
- TPSA ≤ 140 Ų 132.9
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
B([C@H](Cc1cccc(c1)C(=O)O)NC(=O)[C@@H](c2ccccc2)N)(O)OB([C@H](Cc1cccc(c1)C(=O)O)NC(=O)[C@@H](c2ccccc2)N)(O)O
InChI=1S/C17H19BN2O5/c19-15(12-6-2-1-3-7-12)16(21)20-14(18(24)25)10-11-5-4-8-13(9-11)17(22)23/h1-9,14-15,24-25H,10,19H2,(H,20,21)(H,22,23)/t14-,15+/m0/s1InChI=1S/C17H19BN2O5/c19-15(12-6-2-1-3-7-12)16(21)20-14(18(24)25)10-11-5-4-8-13(9-11)17(22)23/h1-9,14-15,24-25H,10,19H2,(H,20,21)(H,22,23)/t14-,15+/m0/s1
WMZXFYUXEUIIHA-LSDHHAIUSA-NWMZXFYUXEUIIHA-LSDHHAIUSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00144' 'PF13354
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 2UL →
- PDB RCSB structure 4oqg →
- UniProt UniProt Q79DR3 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “2UL”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_32248.
PDB 43
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).